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essential for bone growth, and the authors highlight recent
advances in the control of chondrocyte proliferation bybiochemical and mechanical integrity of the skeleton. The
functions of the skeleton, which include its role in growth,
locomotion, ion homeostasis and the protection of vital
organs, are fundamental to the healthy organism. Develop-
ment, growth and maintenance of the skeleton is under
complex endocrine and genetic control and depends on a
tight integration of cellular events within the skeleton and
within the systems that deliver and accumulate mineral for
hydroxyapatite formation (Karsenty 2003).
With few exceptions, bone formation is dependent on the
development of the cartilage anlagen from mesenchymal
precursors. These cartilage models of the future bones are
replaced by bone through endochondral ossification, a process
also responsible for linear bone growth at the epiphyseal plate
during pre- and post-natal life (Kronenberg 2003). In essence,
the laying down of a cartilage matrix by the chondrocyte, the
primary cell type of cartilage, is a pre-requisite for future bone
modelling and remodelling by the osteoblast and osteoclast.
To fully appreciate the contribution of both cartilage and
bone elements to skeletal physiology (and pathology), it is
essential that we more thoroughly understand the molecular
events responsible for the integration of the various signals
and cues that impinge on, and direct, the activities of cartilage
and bone cells.
To this goal, considerable advances have been made in our
understanding of the regulatory mechanisms responsible
for the formation and maintenance of the skeleton. This has
been achieved through various classical in vitro and in vivo
approaches including the analysis of specific knockout
animals, transgenic mice and animals which bear spontaneous
mutations. This progress in our understanding has been
captured in these three thematic reviews, where the authors,
in addition to providing a general review of endochondral
ossification and bone formation and resorption, have focussed
on some of the recent advances in chondrocyte, osteoblast
and osteoclast biology.
In the first thematic review, Mackie et al. (2011) summarise
the current concepts of growth plate chondrocyte activityIndian hedgehog and bone morphogenetic proteins (BMPs).
Of particular interest is the recently recognised cooperation
between Schnurri proteins -2 and -3 and receptor-Smads in
the regulation of BMP signalling (Jones et al. 2010). In
addition, a role for the transcriptional repressor, TRPS1,
which interacts with the activator form of Gli3, in
chondrocyte cycle progression has been proposed (Wuelling
et al. 2009). It is also worthy of mention that TRPS1 appears
to be able to regulate chondrocyte hypertrophy by directly
inhibiting PTHrP expression and RUNX2 function.
This suggests that TRPS1 has an important function in the
fine-tuning of cell-cycle exit and in the transition between
the proliferative and the hypertrophic chondrocyte states
(Napierala et al. 2008).
Mineralisation of the hypertrophic chondrocyte matrix is
followed by vascular invasion of the growth plate, and the
subsequent deposition of the bone matrix by osteoblasts on
the vertical cartilage remnants remaining after osteoclastic
matrix resorption. The regulation of invading cells is now
considered to be an active process in which the chondrocytes
produce factors that promote and attract the invasion of
endothelial cells, osteoblasts and osteoclasts. In the second
thematic review, new insights into osteoblast biology are
summarised with a particular focus on the role of
phosphatidylinositol 3-kinase (PI3K) signalling and its down-
stream effector, AKT (Guntur & Rosen 2011). Of topical
interest is the ability of insulin/IGF1 signalling to up-regulate
PI3K activity and, via the Forkhead group of transcription
factors (FOXOs), influence osteoblast function and energy
metabolism through altered osteocalcin and OST-PTP
expression (Rached et al. 2010, Kousteni 2011). This is
in addition to the previously recognised effects of PI3K
signalling on the osteoblast-specific transcription factors,
RUNX2, Osterix and ATF4. Interestingly, recent data suggest
that conditional loss of Pten, a phosphatase that inactivates
PI3K signalling, in osteoprogenitors results in increased
proliferation of osteoblast progenitors and stimulation of
fibroblast growth factor signalling (Guntur et al. 2011).DOI: 10.1530/JOE-11-0274
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resorbing osteoclast whose function is synchronised to that
of the osteoblast during bone remodelling to ensure bone
mass homeostasis (Mellis et al. 2011). The focus of this
thematic review is the key signalling pathways involved in
osteoclast formation and function. The coupling of osteoblast
and osteoclast function is accepted to involve the receptor
activator of nuclear factor kappa-b (RANK)/osteoprotegrin
(OPG)/RANK ligand (RANKL) system, and this review
summarises in detail the downstream signalling events that
occur after RANK receptor activation, which result in
osteoclast formation and bone resorption. Other pathways are
also involved in osteoclast formation and one of these involves
the ratio of the two isoforms – liver-enriched inhibitory
protein (LIP) and liver-enriched activator protein (LAP) – of
the transcription factor CCAATenhancer-binding protein b.
The ratio of LIP and LAP, which is modulated by the
mechanistic target of rapamycin signalling pathway, regulates
osteoclastogenesis through MafB (Smink et al. 2009). Once
formed, osteoclast attachment to the bone matrix is essential
for resorption and this is mediated by various signalling
pathways such as those initiated by SRC kinase. SRC
phosphorylation of cortactin and gelsolin is important for
actin polymerisation and podosome turnover whereas
phosphorylation of spleen tyrosine kinase, SYK, promotes
the activation of small GTPases and cytoskeletal reorgan-
isation (Itzstein et al. 2011).
The aim of these thematic reviews is to bring together in
one collection an appreciation of our current understanding
of the key factors, e.g. endocrine, genetic and signalling
molecules, that regulate skeletal function via interactions
with cells of both cartilage and bone. Each individual cell
type (including the osteocyte, the terminally differentiated
osteoblast) does not live in isolation or in a vacuum and
there is much crosstalk and communication between them
and also with their collagenous-rich extracellular matrix.
Together, these cellular activities and matrix interactions
result in the formation of a complex organ that is indis-
pensable for life.Declaration of interest
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